Nebilet
Nebilet is a medicine authorised by Swissmedic under authorisation number 54489. The authorisation holder is A. Menarini GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 February 1998 and the authorisation is valid without a time limit. ATC code C07AB12 places the medicine in the group Beta blocking agents.
| Authorisation number | 54489 |
|---|---|
| Name | Nebilet |
| Full name | Nebilet, Tabletten |
| Authorisation holder | A. Menarini GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C07AB12 |
| First authorisation | 26 February 1998 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Nebilet, Tabletten | B | 26 February 1998 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 21 | 28 | Tablette(n) | C07AB12 | 02.03.0. | B |
| 49 | 98 | Tablette(n) | C07AB12 | 02.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Nebilet authorised in Switzerland?
Yes. Nebilet is authorised by Swissmedic under authorisation number 54489, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Nebilet have?
Nebilet is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Nebilet?
The authorisation holder is A. Menarini GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.